Combined Immunodeficiency

Gene: REL

Amber List (moderate evidence)

REL (REL proto-oncogene, NF-kB subunit)
EnsemblGeneIds (GRCh38): ENSG00000162924
EnsemblGeneIds (GRCh37): ENSG00000162924
OMIM: 164910, Gene2Phenotype
REL is in 2 panels

2 reviews

Peter McNaughton (Queensland Children's Hospital)

Green List (high evidence)

2x unrelated patients reported with extensive functional validation.
Created: 12 Sep 2023, 3:12 a.m. | Last Modified: 12 Sep 2023, 3:12 a.m.
Panel Version: 1.43

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Immunodeficiency 92, MIM# 619652; Combined immunodeficiency; T cells: normal, decreased memory CD4, poor proliferation; B cells: low, mostly naive, few switched memory B cells, impaired proliferation; Recurrent infections with bacteria, mycobacteria, salmonella and opportunistic organisms; Defective innate immunity

Publications

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

I don't know

Second unrelated individual reported, with a different homozygous splice site variant.

Immunodeficiency-92 (IMD92) is an autosomal recessive primary immunodeficiency characterized by the onset of recurrent infections in infancy or early childhood. Infectious agents are broad, including bacterial, viral, fungal, and parasitic, including Cryptosporidium and Mycobacteria. Patient lymphocytes show defects in both T- and B-cell proliferation, cytokine secretion, and overall function, and there is also evidence of dysfunction of NK, certain antigen-presenting cells, and myeloid subsets.
Created: 15 Dec 2021, 7:29 a.m. | Last Modified: 15 Dec 2021, 7:29 a.m.
Panel Version: 1.1
Single individual from consanguineous family reported with homozygous canonical splice site variant, no functional data.
Sources: Expert list
Created: 3 Apr 2020, 7:10 a.m.

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Immunodeficiency 92, MIM# 619652; Combined immunodeficiency; T cells: normal, decreased memory CD4, poor proliferation; B cells: low, mostly naive, few switched memory B cells, impaired proliferation; Recurrent infections with bacteria, mycobacteria, salmonella and opportunistic organisms; Defective innate immunity

Publications

Details

Mode of Inheritance
BIALLELIC, autosomal or pseudoautosomal
Sources
  • Expert Review Amber
  • Expert list
Phenotypes
  • Immunodeficiency 92, MIM# 619652
  • Combined immunodeficiency
  • T cells: normal, decreased memory CD4, poor proliferation
  • B cells: low, mostly naive, few switched memory B cells, impaired proliferation
  • Recurrent infections with bacteria, mycobacteria, salmonella and opportunistic organisms
  • Defective innate immunity
OMIM
164910
Clinvar variants
Variants in REL
Penetrance
None
Publications
Panels with this gene

History Filter Activity

15 Dec 2021, Gel status: 2

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Phenotypes for gene: REL were changed from Combined immunodeficiency; T cells: normal, decreased memory CD4, poor proliferation; B cells: low, mostly naive, few switched memory B cells, impaired proliferation; Recurrent infections with bacteria, mycobacteria, salmonella and opportunistic organisms; Defective innate immunity to Immunodeficiency 92, MIM# 619652; Combined immunodeficiency; T cells: normal, decreased memory CD4, poor proliferation; B cells: low, mostly naive, few switched memory B cells, impaired proliferation; Recurrent infections with bacteria, mycobacteria, salmonella and opportunistic organisms; Defective innate immunity

15 Dec 2021, Gel status: 2

Set publications

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Publications for gene: REL were set to 31103457

15 Dec 2021, Gel status: 2

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Gene: rel has been classified as Amber List (Moderate Evidence).

15 Dec 2021, Gel status: 2

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Gene: rel has been classified as Amber List (Moderate Evidence).

3 Apr 2020, Gel status: 1

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Gene: rel has been classified as Red List (Low Evidence).

3 Apr 2020, Gel status: 1

Created, Added New Source, Set mode of inheritance, Set publications, Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

gene: REL was added gene: REL was added to Combined Immunodeficiency. Sources: Expert list Mode of inheritance for gene: REL was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: REL were set to 31103457 Phenotypes for gene: REL were set to Combined immunodeficiency; T cells: normal, decreased memory CD4, poor proliferation; B cells: low, mostly naive, few switched memory B cells, impaired proliferation; Recurrent infections with bacteria, mycobacteria, salmonella and opportunistic organisms; Defective innate immunity Review for gene: REL was set to RED